NIAID announces 25 new awards to develop radiation countermeasures
...rges, M.D. Fred Hutchinson Cancer Research Center, Seattle, WA Andrei V. Gudkov, Ph.D., Cleveland Biolabs, Inc., Buffalo, NY Holger Karsunky, Ph.D., cellerant Therapeutics, Inc., San Carlos, CA Kathleen E. Rodgers, Ph.D., University of Southern California, Los Angeles In addition to the Project BioShiel...Cellerant Therapeutics Awarded $13.5 Million Contract for Treatment of ...
Cellerant Therapeutics Awarded $13.5 Million Contract for Treatment of Acute Radiation Syndrome from the Biomedical Advanced Research and Development Authority ...Cellerant Therapeutics, Inc. Awarded $13.5 Million Contract for ...
... be used to move Cellerant's lead program, a human Myeloid ... Cellerant Therapeutics, Inc. • Biomedical Advanced Research and Development Authority (BARDA) ...Cellerant Therapeutics Announces Publication Confirming Activity of ...
Cellerant Therapeutics Announces Publication Confirming Activity of Myeloid Progenitor Cells in Mouse Model of Chemotherapy-Induced NeutropeniaCellerant Therapeutics Inc. - Company Profile - BioCentury
www.cellerant.com. Development Status. Preclinical (01/07/2007) ... Cellerant Therapeutics Inc. Completed. 05/11/2005. Venture (Series B financing) $25,000,000 ...